In line with these findings, we presumed that the PNI may be a better predictor than serum albumin, inflammation index, or lymphocyte count to predict the ESRD in DN patients, most likely because the PNI is a more comprehensive marker that reflects nutrition, immune and inflammation [24], all of which are closely related with DN. This evidence concerns the gene ALB and liver dysplastic nodule.